First FDA-approved drug for vitiligo is a ‘game changer’ (WTOP.com)

First FDA-approved drug for vitiligo is a ‘game changer’

Vitiligo is an autoimmune condition affecting nearly 2 million Americans. It causes patches of skin to lose color or turn white, and it has no cure. But a new treatment approved by the Food and Drug Administration offers hope.

“The introduction of topical Ruxolitinib is a game changer in the management of vitiligo,” said Dr. Adam Friedman, chair of dermatology at The George Washington University School of Medicine and Health Sciences. “Vitiligo imposes a large burden on patients’ lives and many patients suffer from shame and embarrassment, low self-confidence and social isolation,” he said.

The topical cream takes about six months to work and might not be covered by insurance. 

“It will be an insurance by insurance situation,” Friedman said. “Given this is the only FDA-approved therapy, our hope is that insurance companies will cover it to provide relief for the up to 2% of the population that suffers with this condition.”

 

Read the full article on WTOP.com

Latest News

Among the cancer screenings you should regularly get after age 40, colorectal cancer, a stealthy disease that can have zero symptoms in its early stages, is one of the most important. Matthew Ng, MD, assistant clinical professor of surgery at the George Washington University Medical Faculty…
A panel of GW Cardiologists presented the inaugural GW Medicine Bicentennial Event, titled "Staying Heart Healthy." The panelists presented strategies to maintain a healthy heart and a healthy life.
The George Washington University is pleased to announce that Michael K. Rosner, MD, professor of Neurological Surgery, has been appointed to serve as the chair of the GW Department of Neurological Surgery. The department, known for excellence in patient care and for training generations of…